Novartis starts Entropia pilotCambridge 28 August 2001 Entropia announced the evaluation of its distributed computing platform by leading healthcare company Novartis. The pilot program will demonstrate how the existing network of PCs at Novartis can be transformed into a high-performance compute engine to accelerate drug discovery research. The pilot will be supported locally by Entropia's European office in Cambridge, England.
The
Entropia platform is scalable from just a few machines to thousands and even
millions of PCs.
"The vast quantities of data involved in the genomic era of drug discovery are
quickly outpacing advances in computing technology," said Robert North, Entropia
CEO. "Distributed computing allows companies to cost-effectively access the
massive computing power they'll need by using their existing PC networks. It's
quite exciting that companies like Novartis are deploying our platform to
demonstrate the potential of distributed computing as a valuable tool in drug
discovery efforts."
Ad Emmen [News on Advanced IT] [Calendar] [Analysis] [IT in Medicine] |
 |